GMED - Globus Medical, Inc.
NYSE
->
Healthcare
->
Medical Devices
Audubon,
United States
Type: Equity
GMED price evolution
GMED
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $467.29 | $279.62 | $306.45 | $217.69 |
| Short term investments | $50.5 | $189.31 | $306.38 | $286.69 |
| Net receivables | $503.24 | $494.11 | $240.18 | $222.78 |
| Inventory | $848.13 | $904.98 | $335.56 | $321.03 |
| Total current assets | $1915.37 | $1917.34 | $1210.01 | $1070.43 |
| Long term investments | $75.43 | $275.96 | $391.52 | $480.02 |
| Property, plant & equipment | $646.86 | $701.74 | $248.05 | $245.1 |
| Goodwill & intangible assets | $2359.14 | $2384.05 | $253.83 | $257.9 |
| Total noncurrent assets | $3170.71 | $3438.54 | $1002.46 | $1079.19 |
| Total investments | $125.92 | $465.27 | $697.9 | $766.71 |
| Total assets | $5086.08 | $5355.88 | $2212.47 | $2149.62 |
| Current liabilities | ||||
| Accounts payable | $56.67 | $86.93 | $35.32 | $39.84 |
| Deferred revenue | $18.37 | $17.99 | $14.95 | $13.54 |
| Short long term debt | $11.97 | $13.38 | ||
| Total current liabilities | $392.35 | $428.72 | $155.22 | $167.55 |
| Long term debt | $508.44 | $509.65 | ||
| Total noncurrent liabilities | $695.78 | $739.87 | $72.18 | $67.25 |
| Total debt | $520.4 | $523.03 | ||
| Total liabilities | $1088.12 | $1168.59 | $227.4 | $234.8 |
| Shareholders' equity | ||||
| Retained earnings | $1137.27 | $1347.79 | $1346.79 | $1289.08 |
| Other shareholder equity | -$10.19 | -$18.74 | -$19.07 | -$19.42 |
| Total shareholder equity | $3997.96 | $4187.28 | $1985.07 | $1914.82 |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $467.29 | $150.47 | $193.07 | $239.4 |
| Short term investments | $50.5 | $295.59 | $250.38 | $187.34 |
| Net receivables | $503.24 | $217.31 | $164.44 | $141.68 |
| Inventory | $848.13 | $298.98 | $237 | $229.15 |
| Total current assets | $1915.37 | $983.34 | $864.52 | $821.76 |
| Long term investments | $75.43 | $495.85 | $562.48 | $358.52 |
| Property, plant & equipment | $646.86 | $243.73 | $221.08 | $216.88 |
| Goodwill & intangible assets | $2359.14 | $261.05 | $248.37 | $243.66 |
| Total noncurrent assets | $3170.71 | $1092.78 | $1092.75 | $857.72 |
| Total investments | $125.92 | $791.44 | $812.85 | $545.87 |
| Total assets | $5086.08 | $2076.13 | $1957.26 | $1679.48 |
| Current liabilities | ||||
| Accounts payable | $56.67 | $36.1 | $24.16 | $27.45 |
| Deferred revenue | $18.37 | $14.1 | $12.03 | $8.13 |
| Short long term debt | $11.97 | |||
| Total current liabilities | $392.35 | $159.2 | $140.16 | $120.79 |
| Long term debt | $508.44 | |||
| Total noncurrent liabilities | $695.78 | $70.55 | $75.71 | $52.4 |
| Total debt | $520.4 | $4.8 | ||
| Total liabilities | $1088.12 | $229.75 | $215.88 | $173.19 |
| Shareholders' equity | ||||
| Retained earnings | $1137.27 | $1239.95 | $1194.27 | $1045.08 |
| Other shareholder equity | -$10.19 | -$9.54 | -$6.77 | $3.96 |
| Total shareholder equity | $3997.96 | $1846.37 | $1741.39 | $1506.3 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $616.53 | $383.64 | $291.62 | $276.69 |
| Cost of revenue | $265.49 | $135.39 | $76.47 | $70.83 |
| Gross Profit | $351.05 | $248.25 | $215.14 | $205.86 |
| Operating activities | ||||
| Research & development | $52.25 | $29.33 | $21.35 | $21.08 |
| Selling, general & administrative | $244.72 | $156.21 | $120.07 | $122.42 |
| Total operating expenses | $340.93 | $247.84 | $148.93 | $149.46 |
| Operating income | $10.12 | $0.4 | $66.21 | $56.4 |
| Income from continuing operations | ||||
| EBIT | $27.57 | -$5.38 | $66.38 | $56.69 |
| Income tax expense | $9.96 | $1.54 | $16.96 | $14.06 |
| Interest expense | $2.58 | -$7.92 | -$8.29 | -$6.5 |
| Net income | ||||
| Net income | $15.03 | $1 | $57.71 | $49.13 |
| Income (for common shares) | $15.03 | $1 | $57.71 | $49.13 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $1568.48 | $1022.84 | $958.1 | $789.04 |
| Cost of revenue | $548.17 | $263.73 | $239.22 | $217.46 |
| Gross Profit | $1020.3 | $759.12 | $718.88 | $571.58 |
| Operating activities | ||||
| Research & development | $124.01 | $73.02 | $97.35 | $84.52 |
| Selling, general & administrative | $643.41 | $432.12 | $408.15 | $354.76 |
| Total operating expenses | $887.16 | $531.17 | $546.93 | $460.15 |
| Operating income | $133.14 | $227.95 | $171.95 | $111.43 |
| Income from continuing operations | ||||
| EBIT | $145.26 | $228.79 | $171.11 | $111.95 |
| Income tax expense | $42.52 | $52.85 | $31.22 | $23.61 |
| Interest expense | -$20.13 | -$14.23 | -$9.3 | -$13.95 |
| Net income | ||||
| Net income | $122.87 | $190.17 | $149.19 | $102.28 |
| Income (for common shares) | $122.87 | $190.17 | $149.19 | $102.28 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Net income | $15.03 | $1 | $57.71 | $49.13 |
| Operating activities | ||||
| Depreciation | $71.16 | $37.39 | $18.07 | $18.11 |
| Business acquisitions & disposals | -$293.37 | -$2.66 | ||
| Stock-based compensation | $12.45 | $22.75 | $8.59 | $8.95 |
| Total cash flows from operations | $104.67 | $50.48 | $35.03 | $53.31 |
| Investing activities | ||||
| Capital expenditures | -$22.88 | -$21.53 | -$17.87 | -$15.99 |
| Investments | $343.5 | $234.04 | $70.09 | $29.64 |
| Total cash flows from investing | $320.62 | -$80.86 | $52.22 | $10.99 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$224.52 | $3.3 | $3.2 | $4.86 |
| Net borrowings | ||||
| Total cash flows from financing | -$237.27 | $1.43 | $1.08 | $2.94 |
| Effect of exchange rate | -$0.35 | $2.12 | $0.43 | -$0.03 |
| Change in cash and equivalents | $187.67 | -$26.83 | $88.77 | $67.22 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $122.87 | $190.17 | $149.19 | $102.28 |
| Operating activities | ||||
| Depreciation | $144.73 | $68.25 | $69.87 | $62.87 |
| Business acquisitions & disposals | -$296.03 | -$31.43 | -$34.49 | -$33.48 |
| Stock-based compensation | $52.74 | $32.81 | $30.59 | $27.07 |
| Total cash flows from operations | $243.5 | $178.47 | $276.27 | $198.79 |
| Investing activities | ||||
| Capital expenditures | -$78.27 | -$74.05 | -$56.9 | -$63.66 |
| Investments | $677.27 | -$4.88 | -$284.55 | -$20.18 |
| Total cash flows from investing | $302.97 | -$110.36 | -$375.94 | -$117.32 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$213.16 | -$102.78 | $63.5 | -$32.35 |
| Net borrowings | ||||
| Total cash flows from financing | -$231.82 | -$109.96 | $54.15 | -$38.66 |
| Effect of exchange rate | $2.18 | -$0.75 | -$0.81 | $0.86 |
| Change in cash and equivalents | $316.83 | -$42.6 | -$46.33 | $43.67 |
News
Fundamentals
| Market cap | $6.87B |
|---|---|
| Enterprise value | $6.92B |
| Shares outstanding | 136.34M |
| Revenue | $1.57B |
|---|---|
| EBITDA | $290.00M |
| EBIT | $145.26M |
| Net Income | $122.87M |
| Revenue Q/Q | 124.60% |
| Revenue Y/Y | 53.34% |
| P/E ratio | 55.89 |
|---|---|
| EV/Sales | 4.41 |
| EV/EBITDA | 23.86 |
| EV/EBIT | 47.64 |
| P/S ratio | 4.38 |
| P/B ratio | 1.71 |
| Book/Share | 29.40 |
| Cash/Share | 3.43 |
| EPS | $0.90 |
|---|---|
| ROA | 3.32% |
| ROE | 4.07% |
| Debt/Equity | 0.27 |
|---|---|
| Net debt/EBITDA | 2.14 |
| Current ratio | 4.88 |
| Quick ratio | 2.72 |